Searched for
ABBVIE NEW AGREEMENTS
Dow Jones hits record above 52,000 as Alphabet debuts in index, S&P 500 climbs and Nasdaq jumps over 2% as tech stocks lead Wall Street rally - here's how US stock market performed today (June 29)S&P 500, Dow Jones and Nasdaq today June 29: The US stock market started the shortened trading week with solid gains as the Dow Jones close...- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- TrumpRx explained: How Trump’s new drug price deals with 9 pharma companies could save patients moneyTrumpRx: President Donald Trump has struck new deals with nine major drug companies. These agreements aim to reduce prescription drug price...
- US President Donald Trump to announce new deals to lower drug prices, White House saysPresident Trump is set to announce new agreements Friday aimed at lowering prescription drug prices, with major drugmakers like AbbVie, Bri...
- Trump eyes fresh tariff probe focused on foreign drug pricesPresident Trump is initiating a new investigation into drug prices, aiming to compel foreign nations to pay the same as Americans for their...
- Glenmark shares gain 2% as firm receives $700 million upfront payment from AbbVie dealGlenmark Pharmaceuticals' shares surged following its subsidiary's $700 million upfront payment from AbbVie for an exclusive licensing agre...
- Trump pressures 17 pharma CEOs to cut US drug pricesDonald Trump has asked major pharmaceutical companies to lower US drug prices. He wants them to match the prices paid in other countries. T...
- Glenmark Pharma will turn cash positive with AbbVie's licensing deal: S&PS&P Global Ratings projects Glenmark Pharmaceuticals will achieve a net cash positive position following its licensing agreement with AbbVi...
- Glenmark Pharma shares rally 14% on AbbVie boost; analysts hike targets to Rs 2,800Glenmark Pharma surged 14% after its subsidiary signed a $700 million licensing deal with AbbVie for its experimental cancer drug, ISB 2001...
- Glenmark Pharmaceuticals shares rally up to 20%, mutual funds lead the charge over retail investorsThe shares of Glenmark Pharmaceuticals surged 20% on Friday, July 11, to a day’s high of Rs 2,286 following a landmark $2 billion licensing...
- Motilal Oswal sees 28% upside in Glenmark Pharma, hails $700 mln cancer drug deal as ‘new era’ for innovation playGlenmark Pharma shares: The brokerage noted that the agreement—executed through Glenmark’s subsidiary, Ichnos Glenmark Innovation (IGI)—“va...
- Glenmark Pharma hits 10% upper circuit, scales fresh 52-week high on $700 mn cancer drug dealGlenmark Pharma Share Price: Glenmark Pharmaceuticals' shares soared after its subsidiary, Ichnos Glenmark Innovation, inked a global licen...
- US names first 10 drugs for Medicare price negotiationThe Biden administration has released a list of 10 prescription medicines that will be subject to price negotiations by the U.S. Medicare h...
- Lupin gets USD 25 million from AbbVie for meeting key product development milestoneThe company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor...
- RIL m-cap hits Rs 19 lakh crore as stock surges to all-time highDespite weakness in the broader markets, the largest domestic company rallied 2 per cent to Rs 2,827.10 apiece, its new all-time high.
- Berkshire's bet a bright spot in gloomy year for Big Pharma stocksSo far in 2020, the S&P 500 pharmaceutical industry index has gained 0.6%, versus an 11.7% gain for the overall S&P 500, and an 8.8% gain f...
- Lupin signs second partnership for its oncology pipeline, this time with German drug maker BIBI and Lupin will together develop and commercialise a new drug called MEK inhibitor that will target specific cancer cells and potentially...
- Lupin developing new products to treat cancer, other diseasesSharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to ...
- Lupin partners with AbbVie to develop, commercialise novel oncology drugAdditionally, Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the...
- Tildra approval to give sentimental push to Sun PharmaThe drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune ...
Load More
